JCM
RMD icon

Julex Capital Management’s ResMed RMD Stock Holding History

Julex Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14
Closed -$1.46K – 207
2019
Q1 		$1.46K Hold
14
– – ﹤0.01% 119
2018
Q4 		$1K Buy
+14
New +$1.5K ﹤0.01% 105

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Julex Capital Management's RMD Position: Q2 2019 in Review

Julex Capital Management sold out of ResMed (RMD) in Q2 2019, closing a stake of 14 shares — an estimated $1.46K sold.

Julex Capital Management first reported a position in RMD in Q4 2018 and held it in 2 quarters. The position peaked at $1.46K in Q1 2019. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

  • Julex Capital Management reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
  • Julex Capital Management sold 14 ResMed shares in Q2 2019, an estimated $1.46K.
  • Julex Capital Management first reported a position in ResMed in Q4 2018 and held it in 2 quarters.
  • Julex Capital Management's ResMed position peaked at $1.46K in Q1 2019.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on Julex Capital Management's 13F filing for Q2 2019, filed 29 Oct 2019.